These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12937872)

  • 41. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High antibiotic consumption: a characterization of heavy users in Spain.
    Malo S; José Rabanaque M; Feja C; Jesús Lallana M; Aguilar I; Bjerrum L
    Basic Clin Pharmacol Toxicol; 2014 Sep; 115(3):231-6. PubMed ID: 24517562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
    Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
    Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people.
    Fosbøl EL; Gislason GH; Jacobsen S; Abildstrom SZ; Hansen ML; Schramm TK; Folke F; Sørensen R; Rasmussen JN; Køber L; Madsen M; Torp-Pedersen C
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):822-33. PubMed ID: 18383428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen).
    Vaccheri A; Bjerrum L; Resi D; Bergman U; Montanaro N
    J Antimicrob Chemother; 2002 Dec; 50(6):989-97. PubMed ID: 12461022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Tachecí I; Bradna P; Douda T; Baštecká D; Kopáčová M; Rejchrt S; Lutonský M; Soukup T; Bureš J
    Rheumatol Int; 2016 Nov; 36(11):1557-1561. PubMed ID: 27549792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study.
    Ljung R; Lu Y; Lagergren J
    Drugs Aging; 2011 Jun; 28(6):469-76. PubMed ID: 21639406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Profile of prescription and adequacy of treatment with non-steroidal anti-inflammatory drugs in diabetic patients].
    Navarro-Martínez A; Vidal-Martínez M; García-Rosa I; Lázaro-Gómez MJ; Brotons-Román J
    Rev Calid Asist; 2015; 30(5):256-64. PubMed ID: 26346581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
    Steinfeld S; Bjørke PA
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.
    Edelson JT; Tosteson AN; Sax P
    JAMA; 1990 Jul; 264(1):41-7. PubMed ID: 2113103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study.
    Inotai A; Mészáros A
    Acta Pol Pharm; 2012; 69(4):773-7. PubMed ID: 22876621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.
    Metge CJ; Blanchard JF; Peterson S; Bernstein CN
    Am J Gastroenterol; 2001 Dec; 96(12):3348-55. PubMed ID: 11774948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden.
    Magrini N; Einarson T; Vaccheri A; McManus P; Montanaro N; Bergman U
    Eur J Clin Pharmacol; 1997; 53(3-4):185-9. PubMed ID: 9476029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study.
    Möller B; Pruijm M; Adler S; Scherer A; Villiger PM; Finckh A;
    Ann Rheum Dis; 2015 Apr; 74(4):718-23. PubMed ID: 24356672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.
    Sukel MP; van der Linden MW; Chen C; Erkens JA; Herings RM
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):9-19. PubMed ID: 17963198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The lack of awareness of the Israeli population regarding gastrointestinal complications from non-steroidal anti-inflammatory drugs].
    Zandman-Goddard G; Langevitz P
    Harefuah; 2001 Jun; 140(6):476-8, 567, 566. PubMed ID: 11420844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.